Comorbidities

AB1220 BEHIND THE BRONCHIECTASIS IN SYSTEMIC SCLEROSIS. PREVALENCE AND RISK FACTORS
M. Retuerto-Guerrero, C. Moriano, C. Sieiro Santos, I. González, I. González Fernández, C. Álvarez Castro, C. Díez, P. Pérez-García, J. Ordas Martínez, P. Baenas González, E. Diez Álvarez

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1949; DOI: 10.1136/annrheumdis-2024-eular.6079
AB1236 CASE SERIES OF PATIENTS WITH SYSTEMIC SCLEROSIS AND POSITIVE ANTI-CENTROMERE ANTIBODIES: CLASSIFICATION AND CLINICAL MANIFESTATIONS
L. Salvador Maicas, J. J. Fragío Gil, R. González-Mazarío, P. Martinez Calabuig, M. L. Sanmartín Martínez, A. Sierra Rivera, A. Rueda Cid, J. J. Lerma Garrido, C. Molina Almela, P. T. Timoneda Timoneda, C. Campos Fernández

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1956-1957; DOI: 10.1136/annrheumdis-2024-eular.6044
AB1293 FREQUENCY AND THE EFFECTS OF SPONDYLOARTHRITIS-SPECTRUM DISORDERS ON THE CLINICAL COURSE AND MANAGEMENT OF TAKAYASU ARTERITIS
K. Abacar, S. Kaymaz Tahra, O. Bayindir, B. Ince, M. E. Kutu, A. Yazici, E. Durak Ediboglu, T. Demirci Yildirim, Z. Ademoğlu, A. Omma, N. S. Yasar Bilge, G. Kimyon, T. Kaşifoğlu, H. Emmungil, F. Onen, S. Akar, A. Cefle, N. A. Kanitez, S. Celik, M. Inanc, K. Aksu, G. Keser, H. Direskeneli, F. Alibaz-Oner

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1992-1993; DOI: 10.1136/annrheumdis-2024-eular.5448
AB1307 PREVALENCE AND CAUSES OF HOSPITALIZATION AND MORTALITY IN GIANT CELL ARTERITIS: ANALYSIS OF A MONOCENTRIC RETROSPECTIVE COHORT OF PATIENTS
J. Mora, F. Regola, F. Franceschini, P. Toniati

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 2001; DOI: 10.1136/annrheumdis-2024-eular.4095
AB1089 CORRELATION OF AUTOANTIBODIES AND PERICARDITIS IN SLE PATIENTS
A. Zoto, V. Salko, E. Rapushi, T. Backa

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1873; DOI: 10.1136/annrheumdis-2024-eular.3300
AB1102 PREVALENCE, RISK FACTORS, CLINICAL FEATURES, AND LABORATORY PROFILES OF SYSTEMIC LUPUS ERYTHEMATOSUS IN ADULT RHEUMATOLOGY FOLLOW-UP CLINIC PATIENTS IN ADDIS ABABA, ETHIOPIA
S. Y. Tesfaye, F. Gudeta

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1880; DOI: 10.1136/annrheumdis-2024-eular.4874
AB1154 MATRIX METALLOPROTEINASES, PROMISING BLOOD BIOMARKERS FOR EARLY AND ACCURATE DIAGNOSIS OF SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE
V. Pulito-Cueto, B. Atienza-Mateo, J. G. Ocejo-Vinyals, V. M. Mora-Cuesta, D. Iturbe Fernández, J. Batista-Liz, M. Sebastián Mora-Gil, M. Renuncio-García, E. González López, J. M. Cifrián-Martínez, R. Blanco, R. López-Mejías

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1910-1911; DOI: 10.1136/annrheumdis-2024-eular.1070
AB1172 NEUTROPHIL-TO-LYMPHOCYTE RATE AS A SCREENING TEST FOR SYSTEMIC SCLEROSIS-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION
L. D. Fajardo Hermosillo, M. K. L. López Ramírez

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1919; DOI: 10.1136/annrheumdis-2024-eular.1164
AB1175 RISK OF CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS IS INFLUENCED BY SERUM AUTOANTIBODIES, CUTANEOUS PHENOTYPE, AND IMMUNOSUPPRESSIVE THERAPIES
M. De Santis, A. Tonutti, F. Motta, A. Ceribelli, N. Isailovic, R. Ragusa, C. Selmi

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1921-1922; DOI: 10.1136/annrheumdis-2024-eular.3203
AB1190 EVALUATION OF THE CORRELATION OF PARK-7 EXPRESSION WITH CLINICAL PARAMETERS IN PATIENTS WITH SYSTEMIC SCLEROSIS
E. Ozturk, D. Bulut Gökten, R. Mercan

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 1931; DOI: 10.1136/annrheumdis-2024-eular.10

Main menu

Comorbidities

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Comorbidities

Pages